One CSIC group has incorporated into the Cancer Area at CIMUS
Recently, CIMUS (the Molecular Medicine and Chronic Diseases Research Centre) has added a new group to its Cancer Area thanks to an agreement signed between the University of Santiago de Compostela (USC) and the Spanish Higher Council for Scientific Research (CSIC). This agreement will permit the “Virus and Cancer” group, led by Dr. Carmen Rivas, to undertake its research in this Centre over the next 4 years.
The project that they expect to carry out will centre on the relation between viruses and cancer by means of two research lines: 1) the molecular mechanisms through which viruses cause cancer by employing the virus of Kaposi’s sarcoma as an oncogenic virus model; 2) to evaluate the importance that the cellular proteins involved in the anti-tumoural response have on antiviral defence mechanisms, in particular the role that the SUMO cellular proteins and ubiquitin play in both processes.
Carmen Rivas and her group come from the National Biotechnology Centre in Madrid where they have carried out their most recent research activities, which have led to articles being published in the most prestigious journals in the area of virology, oncology and cell biology. Besides, its research line complements that undertaken by other CIMUS groups in the Cancer Area.
The arrival of this group from the CSIC consolidates the development of the strategy adopted by the USC’s Singular Research Centres and new CSIC groups are expected to be incorporated into this Centre briefly.